NDC 75834-257 – Atorvastatin calcium

Atorvastatin 40 mg/1 · Tablet · Oral

Human Prescription Drug 1 recall

Product NDC75834-257

Product details

Brand name
Atorvastatin calcium
Generic name
Atorvastatin calcium
Labeler
NIVAGEN PHARMACEUTICALS, INC.
Dosage form
Tablet
Route
Oral
Marketing category
ANDA · ANDA213853
Marketed since
August 26, 2020
Listing expires
December 31, 2026
Pharmacologic class
HMG-CoA Reductase Inhibitor

Active ingredients

Uses, dosage, side effects and warnings for Atorvastatin Calcium →

Package NDC codes (4)

Package NDCDescriptionSince
75834-257-011000 TABLET in 1 BOTTLE (75834-257-01)Aug 26, 2020
75834-257-252500 TABLET in 1 BOTTLE (75834-257-25)Aug 26, 2020
75834-257-50500 TABLET in 1 BOTTLE (75834-257-50)Aug 26, 2020
75834-257-9090 TABLET in 1 BOTTLE (75834-257-90)Aug 26, 2020

Recalls mentioning this NDC

Other Atorvastatin Calcium products